about
Classical and recent advances in the treatment of inflammatory bowel diseasesAssociation among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel diseaseThe immune interplay between the host and the pathogen in Aspergillus fumigatus lung infectionAdrenal-Derived Hormones Differentially Modulate Intestinal Immunity in Experimental ColitisTh1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris.An overview of the modulatory effects of oleic acid in health and disease.Cytokine and Chemokines Alterations in the Endemic Form of Pemphigus Foliaceus (Fogo Selvagem).Aedes aegypti salivary gland extract ameliorates experimental inflammatory bowel disease.Morinda citrifolia (Noni) Fruit Juice Reduces Inflammatory Cytokines Expression and Contributes to the Maintenance of Intestinal Mucosal Integrity in DSS Experimental Colitis.The development of Panstrongylus herreri under fluctuating environmental conditions.The impact of intestinal resection on the immune function of short bowel syndrome patients.Trypanosoma cruzi DTU TcII presents higher blood parasitism than DTU TcI in an experimental model of mixed infection.The inhibition of 5-lipoxygenase (5-LO) products leukotriene B4 (LTB4) and cysteinyl leukotrienes (cysLTs) modulates the inflammatory response and improves cutaneous wound healing.Amelioration of experimental colitis after short-term therapy with glucocorticoid and its relationship to the induction of different regulatory markers.Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors.TNF-α blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines.Absence of NOD2 receptor predisposes to intestinal inflammation by a deregulation in the immune response in hosts that are unable to control gut dysbiosisA DTU-dependent blood parasitism and a DTU-independent tissue parasitism during mixed infection of Trypanosoma cruzi in immunosuppressed miceMicrobial-Based Therapies in the Treatment of Inflammatory Bowel Disease - An Overview of Human StudiesPanstrongylus herreri and its ability to develop under fluctuating environmental conditionsSalivary Gland Extract of Kissing Bug, Triatoma lecticularia, Reduces the Severity of Intestinal Inflammation through the Modulation of the Local IL-6/IL-10 AxisPemphigus foliaceus patients (Fogo Selvagem) treated with kinesiotherapy presented lower levels of proinflammatory cytokinesAn introduction of the role of probiotics in human infections and autoimmune diseasesTreatment with a Zinc Metalloprotease Purified from Bothrops moojeni Snake Venom (BmooMP-Alpha-I) Reduces the Inflammation in an Experimental Model of Dextran Sulfate Sodium-Induced ColitisThe role of the triggering receptor expressed on myeloid cells-1 (TREM-1) in non-bacterial infectionsTriggering receptor expressed on myeloid cells-1 (TREM-1) as a therapeutic target in infectious and noninfectious disease: a critical review
P50
Q26861725-200C0DBE-A12C-48D1-A208-A94165CD5968Q27006589-1B4D9F34-9D03-4A38-A432-FA72A161DD43Q28387394-9FCF353D-BF84-4789-8D87-E42DAD5D430EQ37043940-7CD5CD39-F08A-44E7-9B09-32F34EDA22CAQ37685685-BE2584D2-2CCD-4757-91B1-8597D72D000DQ38070690-0F53CDBF-1B50-4A5B-AFE1-854D6ACFE979Q38601424-65E2B5CD-1405-4F52-88EB-BCEA74F47548Q38900135-BB760024-B24D-48D0-B135-E2C6AB638AF0Q38955023-41254761-95E1-4273-B0BE-062EAD6D72D2Q39010910-320571AC-97B6-4F37-86FC-51A46B1B6E83Q39530678-46D0B1CD-3D93-42D1-838E-34349BAC58D4Q41093214-5E53349D-C32A-45D7-9167-3F5EE00DFE83Q48645152-B01137E8-EDB6-49CF-97CA-8CC76D3EE1C9Q51517617-664DA2AA-B1C2-4296-9CFA-371DD4F12014Q52367214-D99A4C6B-5143-4D10-ACDC-045735E36CE5Q55287141-7585032D-20C3-48EC-A52A-116DDD4BDF9EQ57815732-0B1201F7-E488-4112-A08B-BC646E91B557Q58843186-D12E0680-162D-467F-A6B4-E07206DD9E12Q61449579-123E6553-4AD6-4A47-8577-328980CC0549Q88501768-400974F0-211F-450D-8D16-4D7E913DBD33Q91115538-A55DD1EE-F49F-4E1E-A692-996D5CEC925EQ91975345-B45DBE7F-7D26-4CF7-AF8F-545755090408Q92484160-DAE4A5CE-DC83-4BB5-889A-654AB75FA175Q92996166-2089B936-1D3B-4D50-9F56-28D6823F9FADQ93191227-AD0C5AC2-C071-4BE4-AFEF-994657E48E92Q94605504-416BB776-94DD-4F1E-905D-D957268FACA5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Helioswilton Sales-Campos
@ast
Helioswilton Sales-Campos
@en
Helioswilton Sales-Campos
@es
Helioswilton Sales-Campos
@nl
Helioswilton Sales-Campos
@sl
type
label
Helioswilton Sales-Campos
@ast
Helioswilton Sales-Campos
@en
Helioswilton Sales-Campos
@es
Helioswilton Sales-Campos
@nl
Helioswilton Sales-Campos
@sl
altLabel
H.S. Campos
@en
Helioswilton Sales de Campos
@en
Helioswilton Sales-Campos
@en
Ton Campos
@en
Ton Sales
@en
prefLabel
Helioswilton Sales-Campos
@ast
Helioswilton Sales-Campos
@en
Helioswilton Sales-Campos
@es
Helioswilton Sales-Campos
@nl
Helioswilton Sales-Campos
@sl
P1053
O-5367-2017
P106
P1153
55668394800
P2798
P31
P3829
P496
0000-0003-3252-2834